Literature DB >> 11254715

Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2.

H Lindgren1, K Axcrona, T Leanderson.   

Abstract

We have analyzed the murine CD40 ligand promoter with regard to stimulation of transcriptional activity in Jurkat T cells after signaling via the TCR and the costimulatory molecules CD28 and CD2. TCR engagement was necessary for the induction of transcriptional activity from the CD40 ligand promoter, and costimulation through either CD28 or CD2 further increased the activity. Analysis of promoter deletants showed that the DNA elements needed for transcriptional activity induced by costimulatory molecules were located within two regions containing previously identified transcription factor NFAT sites. Further studies of the proximal NFAT site showed that it was not dependent on AP-1 binding for transcriptional activity induced by costimulation through CD28. Instead, a region between the TATA box and the proximal NFAT site was shown to bind proteins of the early growth response family and to contribute to NFAT-mediated transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254715     DOI: 10.4049/jimmunol.166.7.4578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

2.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  CD4⁺ and CD8⁺ T cell-dependent antiviral immunity requires STIM1 and STIM2.

Authors:  Patrick J Shaw; Carl Weidinger; Martin Vaeth; Kevin Luethy; Susan M Kaech; Stefan Feske
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

4.  Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.

Authors:  Chongmin Huan; Matthew L Kelly; Ryan Steele; Iuliana Shapira; Susan R S Gottesman; Christopher A J Roman
Journal:  Nat Immunol       Date:  2006-08-27       Impact factor: 25.606

5.  Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns.

Authors:  Sebastian Bunk; Hanne Schaffert; Bianca Schmid; Christoph Goletz; Sabine Zeller; Marina Borisova; Florian Kern; Jan Rupp; Corinna Hermann
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

Review 6.  CD154 transcriptional regulation in primary human CD4 T cells.

Authors:  Randy Q Cron
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells.

Authors:  Stefano Vavassori; Yufang Shi; Chiann-Chyi Chen; Yacov Ron; Lori R Covey
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

8.  Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region.

Authors:  Jennifer Laughlin; Sanaz Oghlidos; Joseph F Porter; Rodrigo Matus-Nicodemos; Frank L Sinquett; Valentina Marcelli; Lori R Covey
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

9.  A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter.

Authors:  M Brunner; M Zhang; A Genin; I-C Ho; R Q Cron
Journal:  Genes Immun       Date:  2008-08-21       Impact factor: 2.676

10.  Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.

Authors:  Scott A Crist; Daniel L Sprague; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.